APA (7th ed.) Citation

AA, G., HR, S., IA, S., A, P., L, W., J, P., . . . M, S. (2020). A novel terpenoid class for prevention and treatment of KRAS-driven cancers: Comprehensive analysis using in situ, in vitro, and in vivo model systems. Molecular carcinogenesis, 59(8), 886. https://doi.org/10.1002/mc.23200

Chicago Style (17th ed.) Citation

AA, Ganaie, et al. "A Novel Terpenoid Class for Prevention and Treatment of KRAS-driven Cancers: Comprehensive Analysis Using in Situ, in Vitro, and in Vivo Model Systems." Molecular Carcinogenesis 59, no. 8 (2020): 886. https://doi.org/10.1002/mc.23200.

MLA (9th ed.) Citation

AA, Ganaie, et al. "A Novel Terpenoid Class for Prevention and Treatment of KRAS-driven Cancers: Comprehensive Analysis Using in Situ, in Vitro, and in Vivo Model Systems." Molecular Carcinogenesis, vol. 59, no. 8, 2020, p. 886, https://doi.org/10.1002/mc.23200.